1. Market Research
  2. > Pharmaceutical Market Trends

Romania Pharmaceutical Report - Q3, 2014

  • December 2014
  • 14 pages
  • Emerging Markets Direct Media Holdings
Report ID: 3307225

Summary

Table of Contents

This report covers the market developments in Q3/2014, January-September 2014 and the data available as of November 2014.



Most pharmaceutical market indicators recorded y/y decline in January-September 2014, as shown by official statistics. Imports dropped by 1.1% y/y to EUR1.5bn in January-July, after having increased by 7.8% y/y to EUR 2.7bn in full year 2013. Exports also declined by 10.5% y/y over the period. Production of pharmaceuticals shrank by 4.4% y/y in January-August. The retail sales of the broader category of pharmaceutical and cosmetic products also dropped by 15.8% y/y in January-September.



The major deterrents are related to regulatory measures and public spending, as demand for treatment continues to increase and is expected to follow the same upward tendency in the coming years.



The future performance of the market is linked to the update of the reimbursed drug list, which had remained unchanged in the period 2008-2014. In November 2014, the health ministry announced the introduction of 40 new molecules and active substances and a further update of the list by the yearend. In addition to this, the authorities decided to calculate the clawback tax differently for the medicines newly added to the list.



Another important regulatory measure expected on the market is the amendment to the Pharmacy Law regarding demographic criterion. The proposed law, supported by the industry, maintained the demographic criterion that establishes a maximum number of pharmacies per thousand inhabitants in towns. Nonetheless, in October the President sent the law back to Parliament for revision, arguing that the criterion should be eliminated as of end-2015.



Key points:

oPharmaceutical imports, exports decline in Jan-Jul 2014

oPharma market performance in 2015, linked to reimbursed drug list update

oPharma companies to pay different clawback tax for drugs newly added to reimbursed list

oPharmacy Law amendments referred to Parliament for revision

oPolisano's pharmaceutical plant to start oncological drug production next year

oSandoz to invest EUR13mn in expanding production capacity at Targu Mures plant

oADM Farm files to court arrangement procedure with creditors

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...

Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • February 2017
  • by Transparency Market Research

Global Pharmaceutical Hot Melt Extrusion Market: Overview This report provides forecast and analysis of the pharmaceutical hot melt extrusion market on the global and regional levels. It provides historical ...

Pulmonary/ Respiratory Drug Delivery Market by Formulation, Device Type, Canister, End User, Applications - Forecasts to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.